argenx SE (ARGX)
605.92
+9.18
(+1.54%)
USD |
NASDAQ |
Nov 22, 16:00
597.01
-8.91
(-1.47%)
After-Hours: 20:00
argenx Total Assets (Quarterly)
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.797B |
| December 31, 2023 | 4.542B |
| June 30, 2023 | 3.194B |
| December 31, 2022 | 3.134B |
| June 30, 2022 | 3.249B |
| December 31, 2021 | 2.850B |
| June 30, 2021 | 3.213B |
| December 31, 2020 | 2.279B |
| June 30, 2020 | 2.275B |
| December 31, 2019 | 1.610B |
| June 30, 2019 | 1.147B |
| June 30, 2019 | 1.147B |
| December 31, 2018 | 661.70M |
| Date | Value |
|---|---|
| June 30, 2018 | 416.26M |
| June 30, 2018 | 416.26M |
| December 31, 2017 | 444.98M |
| June 30, 2017 | 212.19M |
| December 31, 2016 | 111.24M |
| June 30, 2016 | 130.51M |
| December 31, 2015 | 50.25M |
| June 30, 2015 | 61.15M |
| December 31, 2014 | 71.15M |
| June 30, 2014 | 38.00M |
| March 31, 2014 | 31.00M |
| December 31, 2013 | 34.54M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.610B
Minimum
Dec 2019
4.797B
Maximum
Jun 2024
3.114B
Average
3.164B
Median
Total Assets (Quarterly) Benchmarks
| Biodexa Pharmaceuticals PLC | 17.67M |
| uniQure NV | 645.81M |
| ProQR Therapeutics NV | 119.34M |
| Akari Therapeutics PLC | 2.734M |
| Merus NV | 844.68M |